IL166778A0 - Derivatives of gl ycinergic r(+)-2-amino-3-hydroxypropanoic acid - Google Patents

Derivatives of gl ycinergic r(+)-2-amino-3-hydroxypropanoic acid

Info

Publication number
IL166778A0
IL166778A0 IL16677805A IL16677805A IL166778A0 IL 166778 A0 IL166778 A0 IL 166778A0 IL 16677805 A IL16677805 A IL 16677805A IL 16677805 A IL16677805 A IL 16677805A IL 166778 A0 IL166778 A0 IL 166778A0
Authority
IL
Israel
Prior art keywords
ycinergic
derivatives
amino
hydroxypropanoic acid
hydroxypropanoic
Prior art date
Application number
IL16677805A
Other languages
English (en)
Original Assignee
Prestwick Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prestwick Pharmaceuticals Inc filed Critical Prestwick Pharmaceuticals Inc
Publication of IL166778A0 publication Critical patent/IL166778A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL16677805A 2002-08-14 2005-02-09 Derivatives of gl ycinergic r(+)-2-amino-3-hydroxypropanoic acid IL166778A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0210306A FR2843590B1 (fr) 2002-08-14 2002-08-14 Derives de l'acide r(+)-2-amino-3-hydroxypropanoique a action glycinergique
PCT/FR2003/002447 WO2004016580A2 (fr) 2002-08-14 2003-08-01 Derives de l'acide r(+)-2-amino-3-hydroxypropanoique a action glycinergique

Publications (1)

Publication Number Publication Date
IL166778A0 true IL166778A0 (en) 2006-01-15

Family

ID=30775996

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16677805A IL166778A0 (en) 2002-08-14 2005-02-09 Derivatives of gl ycinergic r(+)-2-amino-3-hydroxypropanoic acid

Country Status (19)

Country Link
US (1) US7488755B2 (zh)
EP (1) EP1529030A2 (zh)
JP (1) JP2005535715A (zh)
KR (2) KR100756138B1 (zh)
CN (1) CN1675169A (zh)
AU (1) AU2003274213B2 (zh)
BR (1) BR0313740A (zh)
CA (1) CA2497347A1 (zh)
CR (1) CR7736A (zh)
EA (1) EA010417B1 (zh)
FR (1) FR2843590B1 (zh)
GE (1) GEP20074194B (zh)
IL (1) IL166778A0 (zh)
MX (1) MXPA05001761A (zh)
NO (1) NO20050961L (zh)
NZ (1) NZ538633A (zh)
PL (1) PL375413A1 (zh)
UA (1) UA80559C2 (zh)
WO (1) WO2004016580A2 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2776388A4 (en) * 2011-11-10 2015-07-08 Davuluri Ramamohan Rao AN INEDIC PROCESS FOR THE PREPARATION OF (R) -N-BENZYL-2-ACETAMIDO-3-METHOXYPROPIONAMIDE

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03236315A (ja) * 1989-12-05 1991-10-22 Nippon Oil & Fats Co Ltd 抗精神病薬
US5332758A (en) * 1990-07-13 1994-07-26 Kanebo, Ltd. Collagen metabolism ameliorant and its use
ES2036926B1 (es) * 1991-08-08 1994-01-16 Uriach & Cia Sa J "procedimiento para la obtencion de derivados de la (2-alquil-3-piridil)metilpiperazina".
GB9425730D0 (en) 1994-12-20 1995-02-22 Nycomed Pharma As Compounds
ES2260773T3 (es) * 1995-12-07 2006-11-01 Daniel C. Javitt Tratamiento de los sintomas negativos y cognitivos de la esquizofreniacon antagonistas de la absorcion de glicina.
IT1283489B1 (it) * 1996-07-23 1998-04-21 Chiesi Farma Spa Ammidi di alfa-amminoacidi,loro preparazione e loro impiego terapeutico
EP1073432B1 (en) * 1998-04-14 2007-08-15 The General Hospital Corporation Use of d-serine or d-alanine for treating schizophrenia
GB2410947B (en) 2004-02-11 2008-09-17 Cambridge Lab Ltd Pharmaceutical compounds

Also Published As

Publication number Publication date
KR20070067250A (ko) 2007-06-27
NO20050961L (no) 2005-04-28
CN1675169A (zh) 2005-09-28
BR0313740A (pt) 2005-07-19
PL375413A1 (en) 2005-11-28
GEP20074194B (en) 2007-09-10
EA010417B1 (ru) 2008-08-29
CR7736A (es) 2008-10-10
FR2843590A1 (fr) 2004-02-20
KR100756138B1 (ko) 2007-09-05
US7488755B2 (en) 2009-02-10
AU2003274213A1 (en) 2004-03-03
CA2497347A1 (en) 2004-02-26
FR2843590B1 (fr) 2007-10-05
UA80559C2 (en) 2007-10-10
MXPA05001761A (es) 2005-04-25
EP1529030A2 (fr) 2005-05-11
JP2005535715A (ja) 2005-11-24
AU2003274213B2 (en) 2008-03-13
KR20050055697A (ko) 2005-06-13
WO2004016580A3 (fr) 2004-04-08
EA200500333A1 (ru) 2005-08-25
WO2004016580A2 (fr) 2004-02-26
NZ538633A (en) 2007-10-26
KR100890674B1 (ko) 2009-03-26
US20050261372A1 (en) 2005-11-24

Similar Documents

Publication Publication Date Title
PL377511A1 (pl) Pochodne kwasu migdałowego
AU2003206803A1 (en) Production of alkenones
EP1620419A4 (en) STABILIZED DERIVATIVES OF ASCORBIC ACID
IL162167A0 (en) Metabolites of (3-äÄ4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-aminoÜ-methylü-phenoxy)-acetic acid
AU2003287912A1 (en) Dicarboxylic acid derivatives as ppar-agonists
IL157176A0 (en) Purification of 2-nitro-4-methylsulphonylbenzoic acid
AU2003269374A1 (en) Heteroaryl-hexanoic acid amide derivatives as immunomodulatory agents
HUP0401641A3 (en) Use of substituted diazonine derivatives as phosphorodiesterase iv inhibitors
AU2003224781A1 (en) Crystalline forms of rabeprazole sodium
GB0129988D0 (en) Imidazolidineacetic acid derivatives
AU2003271910A1 (en) Cladding of rails
IL166778A0 (en) Derivatives of gl ycinergic r(+)-2-amino-3-hydroxypropanoic acid
GB0230240D0 (en) Removal of an acid
AU2003229459A1 (en) Methods of using thiazolidinedithione derivatives
HK1075885A1 (en) 20-Hydroxyeicosatetraenoic acid production inhibitors
AU2003231527A8 (en) Novel derivatives of carnosic acid
AU2003228701A1 (en) Spirobarbituric acid derivatives useful as inhibitors of matrix metalloproteases
AU2003299746A1 (en) Total synthesis of daurichromenic acid
AU2003232362A1 (en) 4-pyrazol-phenylalanine derivatives as ace-nep inhibitors
EP1486485A4 (en) NEW 5-HYDROXYCARBAMIMIDOYL-2-HYDROXYBENZENESULFONAMIDE DERIVATIVE CRYSTALS
AU2002253633A1 (en) 20-hydroxyeicosatetraenoic acid production inhibitors
AU2003238034A1 (en) Novel use of imidazotriazinones
AU2003274043A1 (en) Novel use of dioxocin-5-on derivatives
AU2001276655A1 (en) Derivatives of para-ethoxy-phenillactic acid
AU2002334411A1 (en) Production of usppase